HRTS logo

HRTS Overview

Profile

Name:

Tema Obesity & Cardiometabolic ETF

Assets under management:

$82 M

Expense ratio:

0.75%

Inception date:

-

Website:

-

Last ex-dividend date:

December 11, 2024

Next ex-dividend date:

N/A

Description:

HRTS ETF is an exchange-traded fund that focuses on companies involved in healthcare technology and services. It aims to provide investors with exposure to the growing healthcare sector, offering potential for capital appreciation and diversification within their investment portfolios.

Top holdings

Name
Weight
LLY logo
Eli Lilly and Company(LLY)
10.74 %
UNH logo
UnitedHealth Group Incorporated(UNH)
5.25 %
NOVO NORDISK A/S(NOVO-B.CO)
4.35 %
ASTRAZENECA PLC(AZN.L)
4.05 %
BBIO logo
BridgeBio Pharma(BBIO)
3.98 %
ABT logo
Abbott Laboratories(ABT)
3.81 %
ROCHE HOLDING AG(RHHBY)
3.71 %
VRTX logo
Vertex Pharmaceuticals Incorporated(VRTX)
3.62 %
CHUGAI PHARMACEUTICAL CO., LTD.(4519.T)
3.39 %
MRK logo
Merck & Co(MRK)
3.37 %
TMO logo
Thermo Fisher Scientific(TMO)
3.09 %
BSX logo
Boston Scientific(BSX)
2.99 %
MDT logo
Medtronic(MDT)
2.97 %
GILD logo
Gilead Sciences(GILD)
2.76 %
NOVARTIS AG(NOVN.SW)
2.70 %
AMGN logo
Amgen(AMGN)
2.70 %
ABBV logo
AbbVie(ABBV)
2.55 %
CRNX logo
Crinetics Pharmaceuticals(CRNX)
2.32 %
DHR logo
Danaher(DHR)
1.96 %
BMY logo
Bristol-Myers Squibb(BMY)
1.93 %
REGN logo
Regeneron Pharmaceuticals(REGN)
1.87 %
EW logo
Edwards Lifesciences(EW)
1.87 %
CYTK logo
Cytokinetics Incorporated(CYTK)
1.85 %
DXCM logo
DexCom(DXCM)
1.82 %
PODD logo
Insulet(PODD)
1.78 %
ALNY logo
Alnylam Pharmaceuticals(ALNY)
1.75 %
MCK logo
McKesson(MCK)
1.59 %
ASND logo
Ascendis Pharma A/S(ASND)
1.51 %
MASI logo
Masimo(MASI)
1.36 %
MDGL logo
Madrigal Pharmaceuticals(MDGL)
1.23 %

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$30.78
HRTS price is $30.78

Price All-time High

$36.00
HRTS price is currently -14.50% below its historical high of $36.00

Price Most Recent Change

+1.12%
HRTS price was up +1.12% on Feb 28, 2025

Price YTD Change

+6.62%
HRTS price is up +6.62% since January 1st

Price 1-Year Change

-11.02%
HRTS price is down -11.02% year-on-year

Price 3-Year Change

-
HRTS price 3-year change is unknown

Technical Analysis

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.81
HRTS beta is 0.81

200-day SMA

$32.49
HRTS price is currently -5.26% below its 200-day simple moving average

14-day RSI

59.01
HRTS 14-day relative strength index is 59.01

30-day Relative Volume

1.12
HRTS 30-day relative volume is 1.12

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend per share

Last Paid Dividend

$0.47
HRTS last dividend was $0.47 per share, with an ex-dividend date of December 11, 2024

TTM Dividend Per Share

$0.47
HRTS TTM dividend per share is $0.47

TTM Dividend Per Share 1-Year Change

-
HRTS TTM dividend per share 1-year change is unknown

TTM Dividend Per Share 3-Year Change

-
HRTS TTM dividend per share 3-year change is unknown

Dividend yield

TTM Dividend Yield

1.52%
HRTS TTM dividend yield is 1.52%

TTM Dividend Yield 1-Year Change

-
HRTS TTM dividend yield 1-year change is unknown

Top holdings

Name
Weight
LLY logo
Eli Lilly and Company(LLY)
10.74 %
UNH logo
UnitedHealth Group Incorporated(UNH)
5.25 %
NOVO NORDISK A/S(NOVO-B.CO)
4.35 %
ASTRAZENECA PLC(AZN.L)
4.05 %
BBIO logo
BridgeBio Pharma(BBIO)
3.98 %
ABT logo
Abbott Laboratories(ABT)
3.81 %
ROCHE HOLDING AG(RHHBY)
3.71 %
VRTX logo
Vertex Pharmaceuticals Incorporated(VRTX)
3.62 %
CHUGAI PHARMACEUTICAL CO., LTD.(4519.T)
3.39 %
MRK logo
Merck & Co(MRK)
3.37 %
TMO logo
Thermo Fisher Scientific(TMO)
3.09 %
BSX logo
Boston Scientific(BSX)
2.99 %
MDT logo
Medtronic(MDT)
2.97 %
GILD logo
Gilead Sciences(GILD)
2.76 %
NOVARTIS AG(NOVN.SW)
2.70 %
AMGN logo
Amgen(AMGN)
2.70 %
ABBV logo
AbbVie(ABBV)
2.55 %
CRNX logo
Crinetics Pharmaceuticals(CRNX)
2.32 %
DHR logo
Danaher(DHR)
1.96 %
BMY logo
Bristol-Myers Squibb(BMY)
1.93 %
REGN logo
Regeneron Pharmaceuticals(REGN)
1.87 %
EW logo
Edwards Lifesciences(EW)
1.87 %
CYTK logo
Cytokinetics Incorporated(CYTK)
1.85 %
DXCM logo
DexCom(DXCM)
1.82 %
PODD logo
Insulet(PODD)
1.78 %
ALNY logo
Alnylam Pharmaceuticals(ALNY)
1.75 %
MCK logo
McKesson(MCK)
1.59 %
ASND logo
Ascendis Pharma A/S(ASND)
1.51 %
MASI logo
Masimo(MASI)
1.36 %
MDGL logo
Madrigal Pharmaceuticals(MDGL)
1.23 %

Analyst ratings

FAQ

  • What is HRTS?
  • Does HRTS pay dividends?
  • What stocks are in HRTS?
  • What is the current assets under management for HRTS?
  • What is HRTS average volume?
  • What is HRTS expense ratio?
  • What is HRTS inception date?

What is HRTS?

HRTS ETF is an exchange-traded fund that focuses on companies involved in healthcare technology and services. It aims to provide investors with exposure to the growing healthcare sector, offering potential for capital appreciation and diversification within their investment portfolios.

Does HRTS pay dividends?

Yes, the Tema Obesity & Cardiometabolic ETF does pays dividends, with the most recent payment being $0.47 per share. The last ex-dividend date was on December 11, 2024, and the next ex-dividend date has not been announced yet

What stocks are in HRTS?

As of today, Tema Obesity & Cardiometabolic ETF inlcudes 44 holdings, with 36 of them being companies from 5 different countries and 1 sectors. The most weighted holdings are Eli Lilly and Company (10.74%), UnitedHealth Group Incorporated (5.25%) and NOVO NORDISK A/S (4.35%)

What is the current assets under management for HRTS?

Assets under management of Tema Obesity & Cardiometabolic ETF is $82 M

What is HRTS average volume?

Average volume of Tema Obesity & Cardiometabolic ETF is $28 K

What is HRTS expense ratio?

Expense ratio of Tema Obesity & Cardiometabolic ETF is 0.75%

What is HRTS inception date?

null